Find a specific notice:
Notice Type
Departmental
Notice Title

Renewal of Provisional Consent to the Distribution of a Medicine

Publication Date
4 Mar 2022

Tags

Medicines Act Renewal of provisional consent to the distribution of medicines Health

Notice Number

2022-go757
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product:

Panvax vaccine

Active Ingredient:

Influenza Virus Type A haemagglutinin 30mcg

Dosage Form:

Suspension for injection

New Zealand Sponsor:

Seqirus (NZ) Limited

Manufacturer:

Seqirus Pty Limited, Melbourne, Australia

Note: This consent is given subject to the following condition:

  • The vaccine may only be marketed or distributed in accordance with the directives contained in the current version of the New Zealand Influenza Pandemic Action Plan.

Note: This renewed consent is valid for two years from 6 March 2022.


Dated this 4th day of March 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).